Tubulin-Targeting Agents in Hybrid Drugs
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
609-639
Author(s):
E. C. Breen and J. J. Walsh
Future Prospect of RNA Interference for Cancer Therapies
Journal:
Current Drug Targets
Volume:
11
Page:
345-360
Author(s):
Eishi Ashihara, Eri Kawata and Taira Maekawa
Valproic Acid in the Complex Therapy of Malignant Tumors
Journal:
Current Drug Targets
Volume:
11
Page:
361-379
Author(s):
J. Hrebackova, J. Hrabeta and T. Eckschlager
DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Journal:
Current Molecular Medicine
Volume:
10
Page:
123-132
Author(s):
N. Shivapurkar and A. F. Gazdar
Inhibitors of HDACs - Effective Drugs Against Cancer?
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
210-228
Author(s):
S. Muller and O. H. Kramer
Editorial [Personalized Vaccines and Public Health Genomics: Anticipating and Monitoring the ELSIs]
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
4-6
Author(s):
Y. Joly, K. A. McClellan and B. M. Knoppers
Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
7-24
Author(s):
M. A. Trudeau and J. M.Y. Wong
New Direct and Frontal Tissue Acquisition Tools for Gene Expression Analysis in Personalized Medicine
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
37-48
Author(s):
J. P. Janssens
Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
411-420
Author(s):
David Hirst and Tracy Robson
Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Journal:
Current Drug Targets
Volume:
11
Page:
179-186
Author(s):
P. L. Lakatos and P. Miheller